833 related articles for article (PubMed ID: 32268905)
1. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
[TBL] [Abstract][Full Text] [Related]
2. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
[TBL] [Abstract][Full Text] [Related]
3. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
[TBL] [Abstract][Full Text] [Related]
4. Use of biochemical tests of placental function for improving pregnancy outcome.
Heazell AE; Whitworth M; Duley L; Thornton JG
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.
Duhig K; Seed PT; Placzek A; Sparkes J; Gill C; Brockbank A; Shennan A; Thangaratinam S; Chappell LC
Health Technol Assess; 2021 May; 25(30):1-32. PubMed ID: 34024312
[TBL] [Abstract][Full Text] [Related]
6. Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia.
Griffin M; Seed PT; Duckworth S; North R; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CWG; Shennan AH; Chappell LC
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):387-395. PubMed ID: 28401605
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
[TBL] [Abstract][Full Text] [Related]
8. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Liauw J; Groom K; Ganzevoort W; Gluud C; McKinlay CJD; Sharp A; Mackay L; Kariya C; Lim K; von Dadelszen P; Limpens J; Jakobsen JC;
Syst Rev; 2021 Dec; 10(1):305. PubMed ID: 34861900
[TBL] [Abstract][Full Text] [Related]
9. Prediction of fetal and neonatal outcomes after preterm manifestations of placental insufficiency: systematic review of prediction models.
Kleuskens DG; Van Veen CMC; Groenendaal F; Ganzevoort W; Gordijn SJ; Van Rijn BB; Lely AT; Schuit E; Kooiman J
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):644-652. PubMed ID: 37161550
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation.
Ashoor G; Syngelaki A; Papastefanou I; Nicolaides KH; Akolekar R
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):61-68. PubMed ID: 34643306
[TBL] [Abstract][Full Text] [Related]
11. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
12. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
[TBL] [Abstract][Full Text] [Related]
13. Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia.
Cluver CA; Bergman L; Bergkvist J; Imberg H; Geerts L; Hall DR; Mol BW; Tong S; Walker SP
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):660-667. PubMed ID: 37289938
[TBL] [Abstract][Full Text] [Related]
14. Risk of stillbirth, preterm delivery, and fetal growth restriction following exposure in a previous birth: systematic review and meta-analysis.
Malacova E; Regan A; Nassar N; Raynes-Greenow C; Leonard H; Srinivasjois R; W Shand A; Lavin T; Pereira G
BJOG; 2018 Jan; 125(2):183-192. PubMed ID: 28856792
[TBL] [Abstract][Full Text] [Related]
15. Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
Syngelaki A; Magee LA; von Dadelszen P; Akolekar R; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):367-372. PubMed ID: 35866878
[TBL] [Abstract][Full Text] [Related]
16. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
[TBL] [Abstract][Full Text] [Related]
17. Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.
Meler E; Mazarico E; Eixarch E; Gonzalez A; Peguero A; Martinez J; Boada D; Vellvé K; Gomez-Roig MD; Gratacós E; Figueras F
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):62-69. PubMed ID: 33159370
[TBL] [Abstract][Full Text] [Related]
18. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
Hofmeyr GJ; Manyame S; Medley N; Williams MJ
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806
[TBL] [Abstract][Full Text] [Related]
19. Abnormal placental CD8
Lager S; Sovio U; Eddershaw E; van der Linden MW; Yazar C; Cook E; Happerfield L; Jessop FA; Sebire NJ; Charnock-Jones DS; Smith GCS
J Physiol; 2020 Dec; 598(23):5555-5571. PubMed ID: 32886802
[TBL] [Abstract][Full Text] [Related]
20. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
